GO:0045022 early endosome to late endosome transport: Endosome Maturation Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0045022 describes the directed movement of substances in membrane-bounded vesicles from early sorting endosomes to late sorting endosomes, a process also known as endosome maturation.
• Rab7 is a key regulator of the transition from early to late endocytic compartments, as demonstrated in Xenopus oocytes.
• Endosome maturation involves a series of coordinated steps including cargo sorting, membrane remodeling, and Rab conversion, which are essential for proper protein degradation and recycling [1,6].
• Dysregulation of early endosome to late endosome transport is implicated in various diseases, including cancer, neurodegeneration, and infections [2,5,8].
• Studying this process requires a combination of imaging, proteomics, and genetic perturbation methods, with CRISPR-based models offering precise tools for functional dissection [3,7].
• Key genes involved include RAB5, RAB7, ESCRT components, and SNAREs, which can be targeted for therapeutic intervention.
Description
Early endosome to late endosome transport (GO:0045022) is a fundamental biological process that ensures the proper sorting and delivery of internalized cargo to degradative compartments. This process, often referred to as endosome maturation, involves the conversion of early sorting endosomes into late sorting endosomes, a critical step in the endocytic pathway. It is essential for maintaining cellular homeostasis, as it controls the fate of receptors, nutrients, and pathogens. Defects in this transport step are associated with a wide range of human diseases, including cancer, neurodegenerative disorders, and infectious diseases [2,5]. Understanding the molecular mechanisms of early endosome to late endosome transport is therefore of great interest to researchers in cell biology, pathology, and drug discovery. This article provides a comprehensive overview of the ontology, mechanisms, key genes, and research methods relevant to GO:0045022, based on authoritative QuickGO data and verified PubMed literature.
early endosome to late endosome transport At A Glance
| GO ID | GO:0045022 |
|---|---|
| GO term | early endosome to late endosome transport |
| Ontology | biological_process |
| Synonym | endosome maturation |
| Major function | Directed movement of substances in membrane-bounded vesicles from early sorting endosomes to late sorting endosomes |
| Related cellular component | Endosome membrane, multivesicular body |
| Related molecular function | Rab GTPase activity, SNARE binding |
| Key regulators | Rab5, Rab7, ESCRT complexes |
| Associated diseases | Cancer, neurodegeneration, infections |
What Is GO:0045022?
According to the Gene Ontology, GO:0045022 (early endosome to late endosome transport) is defined as the directed movement of substances, in membrane-bounded vesicles, from the early sorting endosomes to the late sorting endosomes. This process is synonymous with endosome maturation and represents a key step in the endocytic pathway, where cargo destined for degradation is transferred from early endosomes to late endosomes.
Why Is early endosome to late endosome transport Important in Cell Biology?
Early endosome to late endosome transport is crucial for cellular physiology because it governs the degradation of internalized receptors and the recycling of membrane components. This process is a central node in the endocytic network, influencing signal transduction, nutrient uptake, and immune surveillance [1,5]. Its dysregulation can lead to the accumulation of undegraded cargo, altered signaling, and cellular toxicity, which are hallmarks of various diseases. For researchers, understanding this pathway provides insights into basic cell biology and offers potential therapeutic targets for conditions such as cancer and neurodegenerative disorders [2,8].
• Controls the degradation of internalized receptors, thereby regulating cell signaling.
• Essential for nutrient uptake and recycling of membrane components.
• Plays a role in host-pathogen interactions, as some viruses and toxins exploit this pathway [2,8].
• Dysregulation is linked to cancer progression and metastasis.
• Implicated in neurodegenerative diseases such as Alzheimer's and Parkinson's.
• Required for proper immune responses and antigen presentation.
• Serves as a target for therapeutic intervention in infectious diseases.
• Involves Rab GTPases and ESCRT machinery, which are mutated in various disorders.
• Can be studied using advanced imaging and proteomic techniques.
• Provides a model for understanding membrane trafficking and organelle biogenesis.
What Happens During early endosome to late endosome transport?
Cargo Sorting and Vesicle Formation
In simple terms: The cell decides which proteins to send for degradation and packages them into small bubbles.
Early endosomes receive cargo from the plasma membrane and sort them into distinct domains. Ubiquitinated cargo is recognized by ESCRT complexes and packaged into intraluminal vesicles, forming multivesicular bodies (MVBs) [1,6]. This sorting is essential for the subsequent maturation steps and ensures that only appropriate cargo is transported to late endosomes.
Rab Conversion and Membrane Remodeling
In simple terms: The identity of the endosome changes as one molecular switch is replaced by another.
The transition from early to late endosomes is marked by the replacement of Rab5 with Rab7 on the endosomal membrane, a process known as Rab conversion [1,4]. This conversion is regulated by the SAND-1/Mon1-Ccz1 complex and is critical for recruiting late endosomal effectors. Rab7 then promotes the movement of endosomes along microtubules and their fusion with lysosomes [4,7].
Vesicle Transport and Fusion
In simple terms: The bubbles are moved along tracks and then merge with the next compartment.
Late endosomes are transported toward the perinuclear region along microtubules, a process mediated by Rab7 and its effectors such as RILP and FYCO1. Fusion with lysosomes or other late endosomes requires SNARE proteins, including VAMP7 and syntaxin-7, and is regulated by the HOPS complex. This fusion delivers the cargo for degradation.
Regulation by Signaling Pathways
In simple terms: External signals can speed up or slow down this transport process.
The mTORC1 pathway is a key regulator of endosome maturation; when active, it inhibits the transition by phosphorylating components of the machinery. Conversely, nutrient starvation promotes endosome maturation and fusion with lysosomes. Other signaling molecules, such as the ER contact sites, also direct late endosome transport.
Key Genes Involved in GO:0045022 early endosome to late endosome transport
The following genes and proteins are central to early endosome to late endosome transport, as supported by the literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RAB5 | Master regulator of early endosome formation and cargo sorting | Target for studying endosome biogenesis and maturation initiation |
| RAB7 | Regulates transition from early to late endosomes and late endosome transport | Key marker of endosome maturation; mutations linked to Charcot-Marie-Tooth disease |
| ESCRT-0 | Recognizes ubiquitinated cargo and initiates MVB sorting | Involved in cargo selection and intraluminal vesicle formation |
| ESCRT-I | Forms complexes that deform membranes and sort cargo | Essential for MVB biogenesis; mutations associated with cancer |
| ESCRT-II | Works with ESCRT-I and III in cargo sorting | Studied for its role in viral budding and receptor downregulation |
| ESCRT-III | Mediates membrane scission for intraluminal vesicles | Critical for MVB formation; targets for antiviral strategies |
| VPS4 | AAA-ATPase that disassembles ESCRT complexes | Regulates ESCRT recycling; mutations cause neurodegeneration |
| Mon1-Ccz1 | GEF complex that activates Rab7 during Rab conversion | Key regulator of endosome maturation; studied in yeast and metazoans |
| RILP | Rab7 effector that links endosomes to dynein motors | Mediates minus-end directed transport of late endosomes |
| FYCO1 | Rab7 effector that links endosomes to kinesin motors | Mediates plus-end directed transport; mutations cause cataract |
| VAMP7 | SNARE protein mediating fusion of late endosomes with lysosomes | Required for lysosomal delivery; studied in immune cells |
| Syntaxin-7 | SNARE protein involved in late endosome fusion | Part of the fusion machinery; interacts with VAMP7 |
| HOPS complex | Tethering complex that facilitates SNARE-mediated fusion | Essential for endosome-lysosome fusion; mutations cause lysosomal disorders |
| mTORC1 | Kinase complex that inhibits endosome maturation under nutrient-rich conditions | Central regulator of the pathway; target for cancer therapy |
| LAMP1 | Lysosomal marker that accumulates in late endosomes after fusion | Used as a marker for late endosomes/lysosomes in imaging |
| CD63 | Tetraspanin enriched in late endosomes and MVBs | Marker for exosome secretion and endosome maturation |
| CD9 | Tetraspanin involved in exosome biogenesis | Studied for its role in small ectosome secretion |
| Shiga toxin B-subunit | Toxin that exploits early endosome-to-Golgi transport | Used as a tool to study endosome trafficking |
How Is early endosome to late endosome transport Regulated?
Early endosome to late endosome transport is regulated by multiple signaling pathways and protein complexes. The mTORC1 pathway acts as a major checkpoint, inhibiting endosome maturation under nutrient-rich conditions by phosphorylating downstream effectors. Conversely, nutrient starvation promotes maturation and fusion with lysosomes. Rab conversion from Rab5 to Rab7 is a key regulatory step, controlled by the Mon1-Ccz1 GEF complex and the SAND-1 protein. Additionally, ER contact sites provide spatial cues that direct late endosome transport. Ubiquitination and deubiquitination of cargo and machinery also modulate the efficiency of sorting and maturation.
early endosome to late endosome transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RAB7 | Charcot-Marie-Tooth disease type 2B | Knockout or point-mutation in neuronal cell lines; patient-derived iPSCs |
| ESCRT-III | Frontotemporal dementia, ALS | Knockout in SH-SY5Y cells; overexpression of mutant forms |
| VPS4 | Neurodegeneration | Knock-in of disease-associated mutations in HEK293T |
| mTORC1 | Cancer, metabolic disorders | Knockout of TSC1/2 to activate mTORC1; overexpression of constitutively active mutants |
| Shiga toxin receptor (Gb3) | Hemolytic uremic syndrome | Knockout of Gb3 synthase in HeLa cells; toxin uptake assays |
Cancer
Altered endosome maturation is frequently observed in cancer cells, leading to enhanced recycling of growth factor receptors and sustained proliferative signaling. For example, defects in Rab7 or ESCRT components can cause accumulation of activated receptors, promoting tumorigenesis. Targeting early endosome to late endosome transport is being explored as a therapeutic strategy to downregulate oncogenic receptors.
Neurodegenerative Diseases
Neurons are particularly vulnerable to defects in endolysosomal trafficking. Mutations in Rab7 cause Charcot-Marie-Tooth disease type 2B, characterized by peripheral neuropathy. Dysfunction in ESCRT components is linked to frontotemporal dementia and amyotrophic lateral sclerosis. Impaired endosome maturation contributes to the accumulation of toxic protein aggregates in Alzheimer's and Parkinson's diseases.
Infectious Diseases
Many pathogens hijack the endocytic pathway. Shiga toxin exploits early endosome-to-Golgi transport, and inhibiting this step is a potential therapeutic strategy. Viruses such as adenovirus use endosome-to-cytosol transport for infection, and interfering with endosome maturation can block viral replication.
From early endosome to late endosome transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate endosome maturation? | CRISPR knockout of gene X in HeLa or HEK293T cells followed by imaging of Rab5/Rab7 markers |
| Does a point mutation in RAB7 affect transport? | Knock-in of mutant RAB7 using CRISPR in neuronal cells; live-cell imaging |
| What is the role of ESCRT-III in MVB formation? | Inducible overexpression of dominant-negative ESCRT-III in U2OS cells |
| How does mTORC1 inhibition affect endosome maturation? | Knockout of mTOR or treatment with rapamycin; immunofluorescence for LAMP1 |
| Can we rescue a trafficking defect by overexpressing Rab7? | Overexpression of wild-type Rab7 in patient-derived fibroblasts |
| What are the interaction partners of Rab7? | Knock-in of tagged Rab7 (e.g., GFP) for proteomic analysis |
How to Study the early endosome to late endosome transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell fluorescence microscopy | Dynamics of endosome maturation and transport | Visualizing Rab5-to-Rab7 conversion in real time |
| Immunofluorescence | Localization of endosomal markers | Assessing colocalization of cargo with early/late endosome markers |
| AP-MS | Protein-protein interactions | Identifying novel components of the maturation machinery |
| CRISPR knockout | Loss-of-function effects | Determining if a gene is required for endosome maturation |
| CRISPR knock-in | Effects of specific mutations | Modeling disease-associated point mutations in RAB7 |
| RNA-seq | Transcriptional changes | Identifying genes upregulated upon trafficking stress |
| Proximity labeling (BioID) | Interactome in living cells | Mapping the Rab7 interactome |
| Subcellular fractionation | Distribution of proteins across organelles | Quantifying cargo transport from early to late endosomes |
Live-Cell Imaging
Live-cell imaging using fluorescently tagged endosomal markers (e.g., Rab5-GFP, Rab7-RFP) allows real-time visualization of endosome maturation and transport. This method is essential for studying the dynamics of Rab conversion and vesicle movement.
Proteomics and Interactomics
Affinity purification coupled with mass spectrometry (AP-MS) can identify protein complexes involved in endosome maturation, such as ESCRT components and Rab effectors. Proximity labeling (BioID) can capture transient interactions in living cells.
Genetic Perturbation with CRISPR
CRISPR-Cas9 knockout, knock-in, and point mutation models enable precise dissection of gene function in endosome transport [2,7]. These models can be combined with imaging or biochemical assays to assess trafficking defects.
Biochemical Assays
Subcellular fractionation and immunoblotting for endosomal markers (e.g., EEA1, LAMP1) can quantify the distribution of cargo between early and late endosomes. Pulse-chase experiments with radiolabeled ligands measure transport kinetics.
How CRISPR Can Be Used to Study GO:0045022 early endosome to late endosome transport
Knockout
CRISPR knockout of genes such as RAB7, ESCRT components, or mTOR allows researchers to assess their requirement for early endosome to late endosome transport. For example, RAB7 knockout cells exhibit impaired endosome maturation and cargo accumulation. Knockout models are invaluable for identifying essential genes and for drug target validation.
Point Mutation
Introducing disease-associated point mutations (e.g., RAB7 V162M) using CRISPR base editing or HDR enables the study of specific molecular defects. Such models can reveal how mutations affect GTP hydrolysis, effector binding, or transport dynamics.
Knock-in
Knock-in of tagged proteins (e.g., GFP-RAB7) at the endogenous locus allows for physiological expression and real-time tracking of endosomes. This approach is ideal for studying protein localization and dynamics without overexpression artifacts.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of wild-type or mutant proteins can be used to test gain-of-function effects. For instance, overexpressing constitutively active Rab7 can accelerate endosome maturation and enhance degradation.
How EDITGENE Supports early endosome to late endosome transport Research
Researchers studying early endosome to late endosome transport-related genes often need to determine whether a candidate gene is causally involved in the pathway or merely correlated with it. This requires precise genetic models that can knock out, mutate, tag, or overexpress the gene of interest in relevant cell types. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate such investigations, from single-gene editing to high-throughput library screening.
Contact EDITGENE today to design your custom CRISPR model for early endosome to late endosome transport research.
Frequently Asked Questions About early endosome to late endosome transport
What is early endosome to late endosome transport?
It is the directed movement of substances in membrane-bounded vesicles from early sorting endosomes to late sorting endosomes, also known as endosome maturation.
What genes are involved in early endosome to late endosome transport?
Key genes include RAB5, RAB7, ESCRT components (e.g., VPS4), Mon1-Ccz1, and SNAREs such as VAMP7 [1,4,6].
What is the role of Rab7 in endosome maturation?
Rab7 regulates the transition from early to late endosomes and is essential for transport and fusion with lysosomes.
How is early endosome to late endosome transport regulated?
It is regulated by Rab conversion, mTORC1 signaling, and ER contact sites, among other factors [1,7].
What diseases are associated with defects in endosome maturation?
Defects are linked to cancer, neurodegenerative diseases (e.g., Charcot-Marie-Tooth), and infections [2,4,8].
What methods are used to study early endosome to late endosome transport?
Common methods include live-cell imaging, proteomics, CRISPR knockout, and biochemical assays [3,6].
Can CRISPR be used to study endosome maturation?
Yes, CRISPR knockout, knock-in, and point mutation models are powerful tools for dissecting gene function in this pathway [2,4].
What is the difference between early and late endosomes?
Early endosomes are the first sorting station, while late endosomes are more acidic and closer to lysosomes, marked by Rab7 and LAMP1.
How does mTORC1 affect endosome maturation?
mTORC1 inhibits endosome maturation under nutrient-rich conditions, while its inhibition promotes fusion with lysosomes.
What are ESCRT complexes and their role in endosome maturation?
ESCRT complexes sort ubiquitinated cargo into intraluminal vesicles and mediate membrane scission during MVB formation.
Conclusion
Early endosome to late endosome transport (GO:0045022) is a cornerstone of the endocytic pathway, ensuring proper cargo degradation and cellular homeostasis. Its dysregulation underlies numerous diseases, making it a vibrant area of research. By leveraging CRISPR-based models and advanced imaging, scientists can unravel the molecular details of this process and identify new therapeutic targets. EDITGENE stands ready to support these efforts with tailored gene editing and screening services.
References
- 1. Scott CC et al.. 2014. Endosome maturation, transport and functions.. Semin Cell Dev Biol 31:2-10 PMID: 24709024
- 2. Li D et al.. 2020. Targeting the Early Endosome-to-Golgi Transport of Shiga Toxins as a Therapeutic Strategy.. Toxins (Basel) 12(5) PMID: 32456007
- 3. Mathieu M et al.. 2021. Specificities of exosome versus small ectosome secretion revealed by live intracellular tracking of CD63 and CD9.. Nat Commun 12(1):4389 PMID: 34282141
- 4. Mukhopadhyay A et al.. 1997. Rab7 regulates transport from early to late endocytic compartments in Xenopus oocytes.. J Biol Chem 272(20):13055-9 PMID: 9148916
- 5. Maxfield FR et al.. 2004. Endocytic recycling.. Nat Rev Mol Cell Biol 5(2):121-32 PMID: 15040445
- 6. Solinger JA et al.. 2025. ESCRTing the RABs through conversion.. Biochem Soc Trans 53(2):431-445 PMID: 40605338
- 7. Wijdeven RH et al.. 2015. ER contact sites direct late endosome transport.. Bioessays 37(12):1298-302 PMID: 26440125
- 8. Le Blanc I et al.. 2005. Endosome-to-cytosol transport of viral nucleocapsids.. Nat Cell Biol 7(7):653-64 PMID: 15951806
